# Simon Goldman

> Simon Goldman is a seed investor at Albion Capital Group backing Biotechnology and Pharmaceutical. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Albion Capital Group](https://shizune.co/investors/profile/albion-ventures)
- Location: Cambridge, United Kingdom
- Total investments: 2
- Last investment: Jun 2024
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/simon-goldman-7151584
- Website: https://www.uclb.com/our-people/simon-goldman/

Simon Goldman is a seed investor at Albion Capital Group in Cambridge focused on Biotechnology and Pharmaceutical. Simon Goldman is the Investment Director, of UCL Technology Fund at Albion Capital Group LLP. Simon Goldman attended the University of Cambridge.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 1 | 50% |
| Pharmaceutical | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Venture - Series Unknown | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| EpilepsyGTx | EpilepsyGTx is a late-stage biotech company exploring cutting-edge gene therapies to improve the management of focal refractory epilepsy (FRE). | $10M | Seed | Jun 24, 2024 |  |
| AstronauTx | AstronauTx is a UCL spin-off, will develop medicines designed to reset the behaviour of astrocytes. | $1.2M | Venture - Series Unknown | Mar 24, 2020 |  |

2 of 2 investments shown.

## Co-investors
- [HTH](https://shizune.co/investors/profile/hth) — VC Fund, 1 deal together

## About Albion Capital Group

VC Fund · London, United Kingdom

Albion typically invests £2-5m for a minority stake Series A and early Series B. They support outstanding entrepreneurs who have demonstrated product-market fit, a clear go to market strategy and long term differentiation in a growth market.They look at most sectors, with a particular focus on digital B2B companies – enterprise software andtechnology services – across a broad range of sectors, including digital health, cybersecurity, martech and fintech. Companies that benefit from macro themes around disruption, digital transformation, and the trend towards a data-driven economy are particularly attractive. They also invest in companies commercialising IP from University College London via the UCL Technology Fund.

5 contacts available at Albion Capital Group.

| Name | Title | Profile |
| --- | --- | --- |
| Adam Chirkowski | Investment Director | https://shizune.co/investors/profile/adam-chirkowski |
| David Grimm | Investment Director | https://shizune.co/investors/profile/david-grimm-df59 |
| Simon Goldman | Investment Director, UCL Technology Fund | https://shizune.co/investors/profile/simon-goldman |
| Andrew Elder | Partner | https://shizune.co/investors/profile/andrew-elder |
| Andrew Impey | Partner | https://shizune.co/investors/profile/andrew-impey |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Simon Goldman invest in?

Simon Goldman invests primarily in Biotechnology and Pharmaceutical startups, most often at Seed and Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Simon Goldman last invest?

The most recent investment recorded for Simon Goldman closed in Jun 2024. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co